Close Menu

MDS Pharma Services, Caprion Pharmaceuticals, Gentris, and Massachusetts General Hospital's department of radiology have teamed up to form a new Biomarker Alliance that offers clients proteomic, genomic, bioanalytic, and imaging technologies for developing biomarkers, the groups said last week.

Fred Pritchard, vice president of drug development programs at MDS Pharma Services, said that the idea behind the alliance is to enable clients to approach its members and discuss what might be the best one or two tools or techniques to apply to a particular question.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.